Table 1.
Tumor type | n | DICER1 hotspot mutant (n) | p.E1705K (c.5113G>A) (n) | p.D1709N (c.5125G>A) (n) | p.E1813Q (c.5437G>C) (n) | p.G1809R (c.5658G>A) (n) |
---|---|---|---|---|---|---|
Sertoli-Leydig cell tumor (all) | 32 | 20 (63%) | 16 | 1 | 2 | 1 |
Well-differentiated Sertoli-Leydig cell tumor | 2 | 0 (0%) | ||||
Intermediately-differentiated Sertoli-Leydig cell tumor1 | 20 | 14 (70%) | 13 | 1 | ||
Sertoli-Leydig cell tumor with gastrointestinal-type heterologous | 4 | 3 (75%) | 3 | |||
Sertoli-Leydig cell tumor with retiform features | 6 | 3 (50%) | 2 | 1 | ||
Poorly-differentiated Sertoli-Leydig cell tumor2 | 10 | 6 (60%) | 3 | 1 | 2 | |
Sertoli-Leydig cell tumor with rhabdomyosarcomatous differentiation | 4 | 3 (75%) | 2 | 1 | ||
Gynandroblastoma | 5 | 2 (40%) | 2 | |||
Sertoli cell tumor | 8 | 5 (63%) | 5 | |||
Sex cord tumor with annular tubules | 1 | 0 (0%) | ||||
Sex cord stromal tumor not otherwise specified | 1 | 0 (0%) | ||||
Embryonal rhabdomyosarcoma (pediatric) | 2 | 0 (0%) | ||||
Primary uterine rhabdomyosarcoma (adult) | 4 | 1 (25%) | 1 | |||
Carcinosarcoma with rhabdomyosarcomatous differentiation (adult) | 4 | 1 (25%) | 1 | |||
Testicular sex cord stromal tumor | 15 | 0 (0%) |
Tumor category includes Sertoli-Leydig cell tumors with retiform or gastrointestinal-type heterologous elements;
Tumor category includes Sertoli-Leydig cell tumors with rhabdomyosarcomatous elements.